Sirolimus-Based Immunosuppressive Therapy in Liver Transplant Recipient With Tacrolimus-Related Chronic Renal Insufficiency

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1541-1544

  Yang, Y J ^a   Chen, D Z ^a   Li, L X ^a   Kou, J T ^a   Lang, R ^a   Jin, Z K ^a   Han, D D ^a   He, Q ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANKLE EDEMA; ARTHRALGIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DERMATITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; LIVER BIOPSY; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MALE; MONOTHERAPY; MOUTH ULCER; NEPHROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT INDICATION;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SAFETY; SIROLIMUS; TACROLIMUS;

EID: 45449115549     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.01.081     Document Type: Article

References (21)

1. Trotter J.F. Sirolimus in liver transplantation. Transplant Proc 35 suppl (2003) 193S
2. Sindhi R., Seward J., Mazariegos G., et al. Replacing calcineurin inhibitors with mTOR inhibitors in children. Pediatr Transplant 9 (2005) 391
3. Casas-Melley A.T., Falkenstein K.P., Flynn L.M., et al. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr Transplant 8 (2004) 362
4. Lam P., Yoshida A., Brown K., et al. The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors. Dig Dis Sci 49 (2004) 1029
5. Kniepeiss D., Iberer F., Schaffellner S., et al. Nonnephrotoxic immunosuppression in patients after liver transplantation. Int Immunopharmacol 5 (2005) 133
6. Neff G.W., Montalbano M., and Tzakis A.G. Ten years of sirolimus therapy in orthotopic liver transplant recipients. Transplant Proc 35 (2003) 209S
7. Kniepeiss D., Iberer F., Grasser B., et al. Sirolimus and mycophenolate mofetil after liver transplantation. Transpl Int 16 (2003) 504
8. Garrean S., Massad M.G., Tshibaka M., et al. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant 19 (2005) 698
9. Gault M.H., Longerich L.L., Harnett J.D., et al. Predicting glomerular function from adjusted serum creatinine. Nephron 62 (1992) 249
10. Barkmann A., Nashan B., Schmidt H.H., et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 69 (2000) 1886
11. Morard I., Mentha G., Spahr L., et al. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant 20 (2006) 96
12. Gonwa T.A., Mai M.L., Melton L.B., et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 72 (2001) 1934
13. Burdmann E.A., Andoh T.F., Yu L., et al. Cyclosporine nephrotoxicity. Semin Nephrol 23 (2003) 465
14. Chang G.J., Mahanty H.D., Quan D., et al. Experience with the use of sirolimus in liver transplantation-use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl 6 (2000) 734
15. Fairbanks K.D., and Thuluvath P.J. Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience. Liver Transpl 10 (2004) 1189
16. Moreno J.M., Rubio E., Gómez A., et al. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. Transplant Proc 35 (2003) 1874
17. Pierini A., Mirabella S., Brunati A., et al. Mycophenolate mofetil monotherapy in liver transplantation. Transplant Proc 37 (2005) 2614
18. Evans H.M., McKiernan P.J., and Kelly D.A. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 79 (2005) 1575
19. Montalbano M., Neff G.W., Yamashiki N., et al. A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation 78 (2004) 264
20. Markiewicz M., Kalicinski P., Teisseyre J., et al. Rapamycin in children after liver transplantation. Transplant Proc 35 (2003) 2284
21. Forgacs B., Merhav H.J., Lappin J., et al. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 37 (2005) 1912